Individual differences in cognitive aging: implication of pregnenolone sulfate

In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation bet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neurobiology 2003-09, Vol.71 (1), p.43-48
Hauptverfasser: Mayo, Willy, George, Olivier, Darbra, Sonia, Bouyer, Jean-Jacques, Vallée, Monique, Darnaudéry, Muriel, Pallarès, Marc, Lemaire-Mayo, Valérie, Le Moal, Michel, Piazza, Pier-Vincenzo, Abrous, Nora
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 48
container_issue 1
container_start_page 43
container_title Progress in neurobiology
container_volume 71
creator Mayo, Willy
George, Olivier
Darbra, Sonia
Bouyer, Jean-Jacques
Vallée, Monique
Darnaudéry, Muriel
Pallarès, Marc
Lemaire-Mayo, Valérie
Le Moal, Michel
Piazza, Pier-Vincenzo
Abrous, Nora
description In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation between the cognitive performance and the cerebral concentration of a neurosteroid, the pregnenolone sulfate (PREG-S). Neurotransmitter systems modulated by this neurosteroid were unknown until our recent report of an enhancement of acetylcholine (ACh) release in basolateral amygdala, cortex and hippocampus induced by intracerebroventricular (i.c.v.) or intracerebral administrations of PREG-S. Central ACh neurotransmission is known to be involved in the regulation of memory processes and is affected in normal aging and severely altered in human neurodegenerative pathologies like Alzheimer's disease. In the central nervous system, ACh neurotransmission is also involved in the modulation of sleep-wakefulness cycle, and particularly the paradoxical sleep (PS). Relationships between paradoxical sleep and memory are documented in the literature in old animals in which the spatial memory performance positively correlates with the basal amounts of paradoxical sleep. PREG-S infused at the level of ACh cell bodies (nucleus basalis magnocellularis, NBM, or pedunculopontine nucleus, PPT) increases paradoxical sleep in young animals.Finally, aging related cognitive dysfunctions, particularly those observed in Alzheimer's disease, have also been related to alterations of mechanisms underlying cerebral plasticity. Amongst these mechanisms, neurogenesis has been extensively studied recently. Our data demonstrate that PREG-S central infusions dramatically increase neurogenesis, this effect could be related to the negative modulator properties of this steroid at the GABA(A) receptor level. Taken together these data suggest that neurosteroids can influence cognitive processes, particularly in senescent subjects, through a modulation of ACh neurotransmission associated with paradoxical sleep modifications; furthermore, our recent data suggest a critical role for neurosteroids in the modulation of cerebral plasticity, mainly on hippocampal neurogenesis.
doi_str_mv 10.1016/j.pneurobio.2003.09.006
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02323887v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18841752</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-53abd11c467e16318d147d472b39cc6da8f050ca5562e64c3dd81e8e83106d813</originalsourceid><addsrcrecordid>eNqFkTtPwzAQgD2AoBT-AmRCYmi4ixPHZasQj0oVLDBbrn0prlI7xEkl_j2NWpWR6U6n7x66j7EbhBQBxf06bTz1bVi6kGYAPIVpCiBO2Ag44ARAZufsIsY17Koc-Bk7x1wgSiFG7G3urds62-s6sa6qqCVvKCbOJyasvOvclhK9cn71kLhNUzujOxd8EqqkaWnlyYc6eEpiX1e6o0t2Wuk60tUhjtnn89PH4-tk8f4yf5wtJoaXopsUXC8toslFSSg4Sot5afMyW_KpMcJqWUEBRheFyEjkhlsrkSRJjiB2KR-zu_3cL12rpnUb3f6ooJ16nS3UUIOMZ1zKcjuwt3u2acN3T7FTGxcN1bX2FPqoSuRCTHf4fyBKmWNZDGC5B00bYmypOp6AoAYnaq2OTtTgRMFUDd8fs-vDin65IfvXdxDCfwGkjYy-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18841752</pqid></control><display><type>article</type><title>Individual differences in cognitive aging: implication of pregnenolone sulfate</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mayo, Willy ; George, Olivier ; Darbra, Sonia ; Bouyer, Jean-Jacques ; Vallée, Monique ; Darnaudéry, Muriel ; Pallarès, Marc ; Lemaire-Mayo, Valérie ; Le Moal, Michel ; Piazza, Pier-Vincenzo ; Abrous, Nora</creator><creatorcontrib>Mayo, Willy ; George, Olivier ; Darbra, Sonia ; Bouyer, Jean-Jacques ; Vallée, Monique ; Darnaudéry, Muriel ; Pallarès, Marc ; Lemaire-Mayo, Valérie ; Le Moal, Michel ; Piazza, Pier-Vincenzo ; Abrous, Nora</creatorcontrib><description>In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation between the cognitive performance and the cerebral concentration of a neurosteroid, the pregnenolone sulfate (PREG-S). Neurotransmitter systems modulated by this neurosteroid were unknown until our recent report of an enhancement of acetylcholine (ACh) release in basolateral amygdala, cortex and hippocampus induced by intracerebroventricular (i.c.v.) or intracerebral administrations of PREG-S. Central ACh neurotransmission is known to be involved in the regulation of memory processes and is affected in normal aging and severely altered in human neurodegenerative pathologies like Alzheimer's disease. In the central nervous system, ACh neurotransmission is also involved in the modulation of sleep-wakefulness cycle, and particularly the paradoxical sleep (PS). Relationships between paradoxical sleep and memory are documented in the literature in old animals in which the spatial memory performance positively correlates with the basal amounts of paradoxical sleep. PREG-S infused at the level of ACh cell bodies (nucleus basalis magnocellularis, NBM, or pedunculopontine nucleus, PPT) increases paradoxical sleep in young animals.Finally, aging related cognitive dysfunctions, particularly those observed in Alzheimer's disease, have also been related to alterations of mechanisms underlying cerebral plasticity. Amongst these mechanisms, neurogenesis has been extensively studied recently. Our data demonstrate that PREG-S central infusions dramatically increase neurogenesis, this effect could be related to the negative modulator properties of this steroid at the GABA(A) receptor level. Taken together these data suggest that neurosteroids can influence cognitive processes, particularly in senescent subjects, through a modulation of ACh neurotransmission associated with paradoxical sleep modifications; furthermore, our recent data suggest a critical role for neurosteroids in the modulation of cerebral plasticity, mainly on hippocampal neurogenesis.</description><identifier>ISSN: 0301-0082</identifier><identifier>DOI: 10.1016/j.pneurobio.2003.09.006</identifier><identifier>PMID: 14611866</identifier><language>eng</language><publisher>England: Elsevier</publisher><subject>Acetylcholine - physiology ; Aging - physiology ; Animals ; Brain - drug effects ; Brain - physiology ; Cognition - physiology ; Cognitive science ; Humans ; Neuronal Plasticity - drug effects ; Neuronal Plasticity - physiology ; Neuroscience ; Pregnenolone - pharmacology ; Pregnenolone - physiology ; Sleep - drug effects ; Sleep - physiology</subject><ispartof>Progress in neurobiology, 2003-09, Vol.71 (1), p.43-48</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-53abd11c467e16318d147d472b39cc6da8f050ca5562e64c3dd81e8e83106d813</citedby><cites>FETCH-LOGICAL-c376t-53abd11c467e16318d147d472b39cc6da8f050ca5562e64c3dd81e8e83106d813</cites><orcidid>0000-0003-0209-3880 ; 0000-0002-3642-4257</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14611866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02323887$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayo, Willy</creatorcontrib><creatorcontrib>George, Olivier</creatorcontrib><creatorcontrib>Darbra, Sonia</creatorcontrib><creatorcontrib>Bouyer, Jean-Jacques</creatorcontrib><creatorcontrib>Vallée, Monique</creatorcontrib><creatorcontrib>Darnaudéry, Muriel</creatorcontrib><creatorcontrib>Pallarès, Marc</creatorcontrib><creatorcontrib>Lemaire-Mayo, Valérie</creatorcontrib><creatorcontrib>Le Moal, Michel</creatorcontrib><creatorcontrib>Piazza, Pier-Vincenzo</creatorcontrib><creatorcontrib>Abrous, Nora</creatorcontrib><title>Individual differences in cognitive aging: implication of pregnenolone sulfate</title><title>Progress in neurobiology</title><addtitle>Prog Neurobiol</addtitle><description>In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation between the cognitive performance and the cerebral concentration of a neurosteroid, the pregnenolone sulfate (PREG-S). Neurotransmitter systems modulated by this neurosteroid were unknown until our recent report of an enhancement of acetylcholine (ACh) release in basolateral amygdala, cortex and hippocampus induced by intracerebroventricular (i.c.v.) or intracerebral administrations of PREG-S. Central ACh neurotransmission is known to be involved in the regulation of memory processes and is affected in normal aging and severely altered in human neurodegenerative pathologies like Alzheimer's disease. In the central nervous system, ACh neurotransmission is also involved in the modulation of sleep-wakefulness cycle, and particularly the paradoxical sleep (PS). Relationships between paradoxical sleep and memory are documented in the literature in old animals in which the spatial memory performance positively correlates with the basal amounts of paradoxical sleep. PREG-S infused at the level of ACh cell bodies (nucleus basalis magnocellularis, NBM, or pedunculopontine nucleus, PPT) increases paradoxical sleep in young animals.Finally, aging related cognitive dysfunctions, particularly those observed in Alzheimer's disease, have also been related to alterations of mechanisms underlying cerebral plasticity. Amongst these mechanisms, neurogenesis has been extensively studied recently. Our data demonstrate that PREG-S central infusions dramatically increase neurogenesis, this effect could be related to the negative modulator properties of this steroid at the GABA(A) receptor level. Taken together these data suggest that neurosteroids can influence cognitive processes, particularly in senescent subjects, through a modulation of ACh neurotransmission associated with paradoxical sleep modifications; furthermore, our recent data suggest a critical role for neurosteroids in the modulation of cerebral plasticity, mainly on hippocampal neurogenesis.</description><subject>Acetylcholine - physiology</subject><subject>Aging - physiology</subject><subject>Animals</subject><subject>Brain - drug effects</subject><subject>Brain - physiology</subject><subject>Cognition - physiology</subject><subject>Cognitive science</subject><subject>Humans</subject><subject>Neuronal Plasticity - drug effects</subject><subject>Neuronal Plasticity - physiology</subject><subject>Neuroscience</subject><subject>Pregnenolone - pharmacology</subject><subject>Pregnenolone - physiology</subject><subject>Sleep - drug effects</subject><subject>Sleep - physiology</subject><issn>0301-0082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkTtPwzAQgD2AoBT-AmRCYmi4ixPHZasQj0oVLDBbrn0prlI7xEkl_j2NWpWR6U6n7x66j7EbhBQBxf06bTz1bVi6kGYAPIVpCiBO2Ag44ARAZufsIsY17Koc-Bk7x1wgSiFG7G3urds62-s6sa6qqCVvKCbOJyasvOvclhK9cn71kLhNUzujOxd8EqqkaWnlyYc6eEpiX1e6o0t2Wuk60tUhjtnn89PH4-tk8f4yf5wtJoaXopsUXC8toslFSSg4Sot5afMyW_KpMcJqWUEBRheFyEjkhlsrkSRJjiB2KR-zu_3cL12rpnUb3f6ooJ16nS3UUIOMZ1zKcjuwt3u2acN3T7FTGxcN1bX2FPqoSuRCTHf4fyBKmWNZDGC5B00bYmypOp6AoAYnaq2OTtTgRMFUDd8fs-vDin65IfvXdxDCfwGkjYy-</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Mayo, Willy</creator><creator>George, Olivier</creator><creator>Darbra, Sonia</creator><creator>Bouyer, Jean-Jacques</creator><creator>Vallée, Monique</creator><creator>Darnaudéry, Muriel</creator><creator>Pallarès, Marc</creator><creator>Lemaire-Mayo, Valérie</creator><creator>Le Moal, Michel</creator><creator>Piazza, Pier-Vincenzo</creator><creator>Abrous, Nora</creator><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-0209-3880</orcidid><orcidid>https://orcid.org/0000-0002-3642-4257</orcidid></search><sort><creationdate>20030901</creationdate><title>Individual differences in cognitive aging: implication of pregnenolone sulfate</title><author>Mayo, Willy ; George, Olivier ; Darbra, Sonia ; Bouyer, Jean-Jacques ; Vallée, Monique ; Darnaudéry, Muriel ; Pallarès, Marc ; Lemaire-Mayo, Valérie ; Le Moal, Michel ; Piazza, Pier-Vincenzo ; Abrous, Nora</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-53abd11c467e16318d147d472b39cc6da8f050ca5562e64c3dd81e8e83106d813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acetylcholine - physiology</topic><topic>Aging - physiology</topic><topic>Animals</topic><topic>Brain - drug effects</topic><topic>Brain - physiology</topic><topic>Cognition - physiology</topic><topic>Cognitive science</topic><topic>Humans</topic><topic>Neuronal Plasticity - drug effects</topic><topic>Neuronal Plasticity - physiology</topic><topic>Neuroscience</topic><topic>Pregnenolone - pharmacology</topic><topic>Pregnenolone - physiology</topic><topic>Sleep - drug effects</topic><topic>Sleep - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayo, Willy</creatorcontrib><creatorcontrib>George, Olivier</creatorcontrib><creatorcontrib>Darbra, Sonia</creatorcontrib><creatorcontrib>Bouyer, Jean-Jacques</creatorcontrib><creatorcontrib>Vallée, Monique</creatorcontrib><creatorcontrib>Darnaudéry, Muriel</creatorcontrib><creatorcontrib>Pallarès, Marc</creatorcontrib><creatorcontrib>Lemaire-Mayo, Valérie</creatorcontrib><creatorcontrib>Le Moal, Michel</creatorcontrib><creatorcontrib>Piazza, Pier-Vincenzo</creatorcontrib><creatorcontrib>Abrous, Nora</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Progress in neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayo, Willy</au><au>George, Olivier</au><au>Darbra, Sonia</au><au>Bouyer, Jean-Jacques</au><au>Vallée, Monique</au><au>Darnaudéry, Muriel</au><au>Pallarès, Marc</au><au>Lemaire-Mayo, Valérie</au><au>Le Moal, Michel</au><au>Piazza, Pier-Vincenzo</au><au>Abrous, Nora</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Individual differences in cognitive aging: implication of pregnenolone sulfate</atitle><jtitle>Progress in neurobiology</jtitle><addtitle>Prog Neurobiol</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>71</volume><issue>1</issue><spage>43</spage><epage>48</epage><pages>43-48</pages><issn>0301-0082</issn><abstract>In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation between the cognitive performance and the cerebral concentration of a neurosteroid, the pregnenolone sulfate (PREG-S). Neurotransmitter systems modulated by this neurosteroid were unknown until our recent report of an enhancement of acetylcholine (ACh) release in basolateral amygdala, cortex and hippocampus induced by intracerebroventricular (i.c.v.) or intracerebral administrations of PREG-S. Central ACh neurotransmission is known to be involved in the regulation of memory processes and is affected in normal aging and severely altered in human neurodegenerative pathologies like Alzheimer's disease. In the central nervous system, ACh neurotransmission is also involved in the modulation of sleep-wakefulness cycle, and particularly the paradoxical sleep (PS). Relationships between paradoxical sleep and memory are documented in the literature in old animals in which the spatial memory performance positively correlates with the basal amounts of paradoxical sleep. PREG-S infused at the level of ACh cell bodies (nucleus basalis magnocellularis, NBM, or pedunculopontine nucleus, PPT) increases paradoxical sleep in young animals.Finally, aging related cognitive dysfunctions, particularly those observed in Alzheimer's disease, have also been related to alterations of mechanisms underlying cerebral plasticity. Amongst these mechanisms, neurogenesis has been extensively studied recently. Our data demonstrate that PREG-S central infusions dramatically increase neurogenesis, this effect could be related to the negative modulator properties of this steroid at the GABA(A) receptor level. Taken together these data suggest that neurosteroids can influence cognitive processes, particularly in senescent subjects, through a modulation of ACh neurotransmission associated with paradoxical sleep modifications; furthermore, our recent data suggest a critical role for neurosteroids in the modulation of cerebral plasticity, mainly on hippocampal neurogenesis.</abstract><cop>England</cop><pub>Elsevier</pub><pmid>14611866</pmid><doi>10.1016/j.pneurobio.2003.09.006</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0209-3880</orcidid><orcidid>https://orcid.org/0000-0002-3642-4257</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0301-0082
ispartof Progress in neurobiology, 2003-09, Vol.71 (1), p.43-48
issn 0301-0082
language eng
recordid cdi_hal_primary_oai_HAL_hal_02323887v1
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylcholine - physiology
Aging - physiology
Animals
Brain - drug effects
Brain - physiology
Cognition - physiology
Cognitive science
Humans
Neuronal Plasticity - drug effects
Neuronal Plasticity - physiology
Neuroscience
Pregnenolone - pharmacology
Pregnenolone - physiology
Sleep - drug effects
Sleep - physiology
title Individual differences in cognitive aging: implication of pregnenolone sulfate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A08%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Individual%20differences%20in%20cognitive%20aging:%20implication%20of%20pregnenolone%20sulfate&rft.jtitle=Progress%20in%20neurobiology&rft.au=Mayo,%20Willy&rft.date=2003-09-01&rft.volume=71&rft.issue=1&rft.spage=43&rft.epage=48&rft.pages=43-48&rft.issn=0301-0082&rft_id=info:doi/10.1016/j.pneurobio.2003.09.006&rft_dat=%3Cproquest_hal_p%3E18841752%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18841752&rft_id=info:pmid/14611866&rfr_iscdi=true